Sun Pharma surges 5% as US arm Taro posts healthy December quarter results

The stock was up 5 per cent at Rs 436 on the BSE in intra-day trade after its US subsidiary Taro Pharmaceutical reported strong results for the quarter ended December 2018.

from Latest News http://bit.ly/2DYk5SA
https://ift.tt/eA8V8J http://bit.ly/2SdCH5P

• Tweet
• Share
• Share
• Share
• Share